Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal Cancer
Clinical trial NCT00544700 · TERMINATED
Trial details
- NCT number
- NCT00544700
- Sponsor
- Swiss Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-26
- Primary completion
- 2013-01-21
- Enrollment
- 265
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.